Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus and Reduced Lipid Level

Doses used in studies

CFU/day: 10 billion (median 10 billion, IQR 10 billion–10 billion) — 1 study

Time to effect

Median: 3.7 months · IQR 3.7 months–3.7 months · Range 3.7 months–3.7 months — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityReported
Adverse events were similarly distributed among groups, indicating comparable safety profiles.
from: Effect of probiotics on glycemic control and lipid profiles in patients with type 2 diabet

1 of 1 paper

Effect of probiotics on glycemic control and lipid profiles in patients with type 2 diabetes mellitus: a randomized, double blind, controlled trial.
- 2024-09-16
- RCT · n = 490
- Frontiers in endocrinology 15
- - Xuchao Peng
  - Hong Xian
  - Ning Ge
  - Lisha Hou
  - Tianjiao Tang
  - Dongmei Xie
  - Langli Gao
  - Jirong Yue
- PubMed: 39351535
- DOI: 10.3389/fendo.2024.1440286
4 Insights on
- Reduced Lipid Level
- High evidence
- Large Human Trial
- Clinical
Overall, 16-week probiotic supplementation showed no beneficial effects on glycemic control, lipid profiles, or weight.
Effect
Neutral
Effect size
Small
Significant
No
Dose
25 ml of a probiotic beverage containing over 10^8 CFU/mL, four times daily